Marksans Pharma received UK regulatory approval to market a Metformin Hydrochloride oral solution for type 2 diabetes, addressing patients with swallowing difficulties. This expands their generic pharmaceutical portfolio globally.
RBL Bank Stock Climbs 3.7%, Citi Hikes Target
NSDL IPO Opens on July 30
Amazon's India Quick-Commerce Challenge
Infosys & Adobe AI Collaboration Boosts Marketing
Vijaya Diagnostic Q1 Profit Surges
Solar, Battery Plant Funding Overview
India Manufacturing Hits 17-Year High
News that matters the most ⚡